<p>資金雄厚的投資者對百時美施貴寶（NYSE: BMY）採取了看漲的態度，這一點市場參與者不應忽視。我們在 Benzinga 對公共期權記錄的跟蹤揭示了今天這一重要舉動。這些投資者的身份仍然未知，但在 BMY 中如此大規模的舉動通常暗示着一些重大事件即將發生。</p>
<p>我們今天的觀察中發現，Benzinga 的期權掃描儀突出了百時美施貴寶的 9 個非凡期權活動。這種活動水平是異常的。</p>
<p>這些重量級投資者的整體情緒分歧，55% 看漲，22% 看跌。在這些顯著的期權中，有 2 個看跌期權，總計 924,240 美元，7 個看漲期權，總計 366,072 美元。</p>
<h3>預測價格目標</h3>
<p>根據交易活動，顯著投資者的目標價格區間為百時美施貴寶在最近三個月內的 25.0 至 52.5 美元。</p>
<h3>成交量與未平倉合約發展</h3>
<p>在今天的交易環境中，百時美施貴寶的期權平均未平倉合約為 1396.11，總成交量達到 4,025.00。附圖描繪了過去 30 天內百時美施貴寶高價值交易的看漲和看跌期權的成交量和未平倉合約的變化。</p>
<h3>百時美施貴寶看漲和看跌期權成交量：30 天概覽</h3>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767376873_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="期權看漲圖表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767376873_0.png"/></p>
<h3>值得注意的期權活動：</h3>
<table>
<thead>
<tr>
<th><strong>符號</strong></th>
<th><strong>看跌/看漲</strong></th>
<th><strong>交易類型</strong></th>
<th><strong>情緒</strong></th>
<th><strong>到期日</strong></th>
<th><strong>賣出價</strong></th>
<th><strong>買入價</strong></th>
<th><strong>價格</strong></th>
<th><strong>行權價</strong></th>
<th><strong>總交易價格</strong></th>
<th><strong>未平倉合約</strong></th>
<th><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BMY</td>
<td>看跌</td>
<td>交易</td>
<td>看漲</td>
<td>12/15/28</td>
<td>$4.95</td>
<td>$4.05</td>
<td>$4.35</td>
<td>$40.00</td>
<td>$863.0K</td>
<td>2</td>
<td>1.9K</td>
</tr>
<tr>
<td>BMY</td>
<td>看漲</td>
<td>掃描</td>
<td>看漲</td>
<td>09/18/26</td>
<td>$12.0</td>
<td>$11.85</td>
<td>$12.0</td>
<td>$43.00</td>
<td>$122.4K</td>
<td>620</td>
<td>105</td>
</tr>
<tr>
<td>BMY</td>
<td>看跌</td>
<td>交易</td>
<td>看跌</td>
<td>06/18/26</td>
<td>$0.36</td>
<td>$0.23</td>
<td>$0.34</td>
<td>$40.00</td>
<td>$61.2K</td>
<td>7.6K</td>
<td>1.8K</td>
</tr>
<tr>
<td>BMY</td>
<td>看漲</td>
<td>交易</td>
<td>看漲</td>
<td>12/15/28</td>
<td>$24.35</td>
<td>$23.25</td>
<td>$24.1</td>
<td>$30.00</td>
<td>$48.2K</td>
<td>5</td>
<td>20</td>
</tr>
<tr>
<td>BMY</td>
<td>看漲</td>
<td>交易</td>
<td>中性</td>
<td>01/16/26</td>
<td>$28.7</td>
<td>$27.7</td>
<td>$28.2</td>
<td>$25.00</td>
<td>$45.1K</td>
<td>971</td>
<td>16</td>
</tr>
</tbody>
</table>
<h3>關於百時美施貴寶</h3>
<p>百時美施貴寶發現、開發並銷售用於各種治療領域的藥物，如心血管、癌症和免疫疾病。百時美的一個關鍵焦點是免疫腫瘤學，該公司在藥物開發方面處於領先地位。百時美近 70% 的總銷售額來自美國，顯示出對美國市場的依賴程度高於大多數同行。</p>
<h3>百時美施貴寶的當前市場地位</h3>
<ul>
<li>在 3,536,753 的交易量下，BMY 的價格下跌了 -0.64%，達到 53.59 美元。</li>
<li>當前 RSI 值表明該股票可能接近超買狀態。</li>
<li>下一次財報預計在 34 天后發佈。</li>
</ul>
<h3>專家對百時美施貴寶的看法</h3>
<p>在過去一個月中，5 位行業分析師分享了他們對該股票的見解，提出的平均目標價格為 53.6 美元。</p>
<p><strong>檢測到異常期權活動：聰明資金在行動</strong></p>
<p>Benzinga Edge 的異常期權板塊在潛在市場動向發生之前發現可能的市場推動者。查看大資金在您喜愛的股票上採取了什麼頭寸。點擊此處訪問。
* B of A Securities 的一位分析師將其評級上調至買入，目標價格為 61 美元。
* Wells Fargo 的一位分析師在評估中保持對百時美施貴寶的持平評級，目標價格為 55 美元。
* Scotiabank 的一位分析師繼續對百時美施貴寶保持行業表現評級，目標價格為 53 美元。
* Morgan Stanley 的一位分析師維持對百時美施貴寶的減持評級，目標價格為 37 美元。
* Guggenheim 的一位分析師積極上調評級至買入，並將目標價格調整至 62 美元。</p>
<p>期權交易存在更高的風險和潛在的回報。精明的交易者通過不斷學習、調整策略、監控多個指標以及密切關注市場動態來管理這些風險。通過 Benzinga Pro 的實時警報，隨時瞭解百時美施貴寶的最新期權交易。</p>

百時美施貴寶

<p>百時美施貴寶 (NYSE:BMY) 最近出現了顯著的看漲期權活動，55% 的投資者持看漲態度。該股票的預計價格區間在 25.0 美元到 52.5 美元之間。目前的交易量為 4,025，平均未平倉合約為 1,396。分析師們的意見各不相同，目標價格範圍從 37 美元到 62 美元不等。該股票目前的價格為 53.59 美元，下跌 0.64%。下一個財報將在 34 天后發佈。建議投資者關注期權交易風險和市場動態</p>

<p>Deep-pocketed investors have adopted a bullish approach towards Bristol-Myers Squibb (NYSE: BMY), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BMY usually suggests something big is about to happen.</p>
<div class="lb-trans"><p>資金雄厚的投資者對百時美施貴寶（NYSE: BMY）採取了看漲的態度，這一點市場參與者不應忽視。我們在 Benzinga 對公共期權記錄的跟蹤揭示了今天這一重要舉動。這些投資者的身份仍然未知，但在 BMY 中如此大規模的舉動通常暗示着一些重大事件即將發生。</p>
</div><p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Bristol-Myers Squibb. This level of activity is out of the ordinary.</p>
<div class="lb-trans"><p>我們今天的觀察中發現，Benzinga 的期權掃描儀突出了百時美施貴寶的 9 個非凡期權活動。這種活動水平是異常的。</p>
</div><p>The general mood among these heavyweight investors is divided, with 55% leaning bullish and 22% bearish. Among these notable options, 2 are puts, totaling $924,240, and 7 are calls, amounting to $366,072.</p>
<div class="lb-trans"><p>這些重量級投資者的整體情緒分歧，55% 看漲，22% 看跌。在這些顯著的期權中，有 2 個看跌期權，總計 924,240 美元，7 個看漲期權，總計 366,072 美元。</p>
</div><h3>Projected Price Targets</h3>
<div class="lb-trans"><h3>預測價格目標</h3>
</div><p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $25.0 to $52.5 for Bristol-Myers Squibb over the recent three months.</p>
<div class="lb-trans"><p>根據交易活動，顯著投資者的目標價格區間為百時美施貴寶在最近三個月內的 25.0 至 52.5 美元。</p>
</div><h3>Volume &amp; Open Interest Development</h3>
<div class="lb-trans"><h3>成交量與未平倉合約發展</h3>
</div><p>In today's trading context, the average open interest for options of Bristol-Myers Squibb stands at 1396.11, with a total volume reaching 4,025.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Bristol-Myers Squibb, situated within the strike price corridor from $25.0 to $52.5, throughout the last 30 days.</p>
<div class="lb-trans"><p>在今天的交易環境中，百時美施貴寶的期權平均未平倉合約為 1396.11，總成交量達到 4,025.00。附圖描繪了過去 30 天內百時美施貴寶高價值交易的看漲和看跌期權的成交量和未平倉合約的變化。</p>
</div><h3>Bristol-Myers Squibb Call and Put Volume: 30-Day Overview</h3>
<div class="lb-trans"><h3>百時美施貴寶看漲和看跌期權成交量：30 天概覽</h3>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767376873_0.png" alt="Options Call Chart" original-src="https://www.benzinga.com/files/images/story/2026/1767376873_0.png"/></p>
<h3>Noteworthy Options Activity:</h3>
<div class="lb-trans"><h3>值得注意的期權活動：</h3>
</div><table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BMY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/15/28</td>
<td>$4.95</td>
<td>$4.05</td>
<td>$4.35</td>
<td>$40.00</td>
<td>$863.0K</td>
<td>2</td>
<td>1.9K</td>
</tr>
<tr>
<td>BMY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$12.0</td>
<td>$11.85</td>
<td>$12.0</td>
<td>$43.00</td>
<td>$122.4K</td>
<td>620</td>
<td>105</td>
</tr>
<tr>
<td>BMY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$0.36</td>
<td>$0.23</td>
<td>$0.34</td>
<td>$40.00</td>
<td>$61.2K</td>
<td>7.6K</td>
<td>1.8K</td>
</tr>
<tr>
<td>BMY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/15/28</td>
<td>$24.35</td>
<td>$23.25</td>
<td>$24.1</td>
<td>$30.00</td>
<td>$48.2K</td>
<td>5</td>
<td>20</td>
</tr>
<tr>
<td>BMY</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$28.7</td>
<td>$27.7</td>
<td>$28.2</td>
<td>$25.00</td>
<td>$45.1K</td>
<td>971</td>
<td>16</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>符號</strong></th>
<th><strong>看跌/看漲</strong></th>
<th><strong>交易類型</strong></th>
<th><strong>情緒</strong></th>
<th><strong>到期日</strong></th>
<th><strong>賣出價</strong></th>
<th><strong>買入價</strong></th>
<th><strong>價格</strong></th>
<th><strong>行權價</strong></th>
<th><strong>總交易價格</strong></th>
<th><strong>未平倉合約</strong></th>
<th><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BMY</td>
<td>看跌</td>
<td>交易</td>
<td>看漲</td>
<td>12/15/28</td>
<td>$4.95</td>
<td>$4.05</td>
<td>$4.35</td>
<td>$40.00</td>
<td>$863.0K</td>
<td>2</td>
<td>1.9K</td>
</tr>
<tr>
<td>BMY</td>
<td>看漲</td>
<td>掃描</td>
<td>看漲</td>
<td>09/18/26</td>
<td>$12.0</td>
<td>$11.85</td>
<td>$12.0</td>
<td>$43.00</td>
<td>$122.4K</td>
<td>620</td>
<td>105</td>
</tr>
<tr>
<td>BMY</td>
<td>看跌</td>
<td>交易</td>
<td>看跌</td>
<td>06/18/26</td>
<td>$0.36</td>
<td>$0.23</td>
<td>$0.34</td>
<td>$40.00</td>
<td>$61.2K</td>
<td>7.6K</td>
<td>1.8K</td>
</tr>
<tr>
<td>BMY</td>
<td>看漲</td>
<td>交易</td>
<td>看漲</td>
<td>12/15/28</td>
<td>$24.35</td>
<td>$23.25</td>
<td>$24.1</td>
<td>$30.00</td>
<td>$48.2K</td>
<td>5</td>
<td>20</td>
</tr>
<tr>
<td>BMY</td>
<td>看漲</td>
<td>交易</td>
<td>中性</td>
<td>01/16/26</td>
<td>$28.7</td>
<td>$27.7</td>
<td>$28.2</td>
<td>$25.00</td>
<td>$45.1K</td>
<td>971</td>
<td>16</td>
</tr>
</tbody>
</table>
</div><h3>About Bristol-Myers Squibb</h3>
<div class="lb-trans"><h3>關於百時美施貴寶</h3>
</div><p>Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.</p>
<div class="lb-trans"><p>百時美施貴寶發現、開發並銷售用於各種治療領域的藥物，如心血管、癌症和免疫疾病。百時美的一個關鍵焦點是免疫腫瘤學，該公司在藥物開發方面處於領先地位。百時美近 70% 的總銷售額來自美國，顯示出對美國市場的依賴程度高於大多數同行。</p>
</div><h3>Present Market Standing of Bristol-Myers Squibb</h3>
<div class="lb-trans"><h3>百時美施貴寶的當前市場地位</h3>
</div><ul>
<li>With a trading volume of 3,536,753, the price of BMY is down by -0.64%, reaching $53.59.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 34 days from now.</li>
</ul>
<div class="lb-trans"><ul>
<li>在 3,536,753 的交易量下，BMY 的價格下跌了 -0.64%，達到 53.59 美元。</li>
<li>當前 RSI 值表明該股票可能接近超買狀態。</li>
<li>下一次財報預計在 34 天后發佈。</li>
</ul>
</div><h3>Expert Opinions on Bristol-Myers Squibb</h3>
<div class="lb-trans"><h3>專家對百時美施貴寶的看法</h3>
</div><p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $53.6.</p>
<div class="lb-trans"><p>在過去一個月中，5 位行業分析師分享了他們對該股票的見解，提出的平均目標價格為 53.6 美元。</p>
</div><p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<div class="lb-trans"><p><strong>檢測到異常期權活動：聰明資金在行動</strong></p>
</div><p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
* An analyst from B of A Securities upgraded its action to Buy with a price target of $61.
* Consistent in their evaluation, an analyst from Wells Fargo keeps a Equal-Weight rating on Bristol-Myers Squibb with a target price of $55.
* An analyst from Scotiabank persists with their Sector Perform rating on Bristol-Myers Squibb, maintaining a target price of $53.
* Maintaining their stance, an analyst from Morgan Stanley continues to hold a Underweight rating for Bristol-Myers Squibb, targeting a price of $37.
* In a positive move, an analyst from Guggenheim has upgraded their rating to Buy and adjusted the price target to $62.</p>
<div class="lb-trans"><p>Benzinga Edge 的異常期權板塊在潛在市場動向發生之前發現可能的市場推動者。查看大資金在您喜愛的股票上採取了什麼頭寸。點擊此處訪問。
* B of A Securities 的一位分析師將其評級上調至買入，目標價格為 61 美元。
* Wells Fargo 的一位分析師在評估中保持對百時美施貴寶的持平評級，目標價格為 55 美元。
* Scotiabank 的一位分析師繼續對百時美施貴寶保持行業表現評級，目標價格為 53 美元。
* Morgan Stanley 的一位分析師維持對百時美施貴寶的減持評級，目標價格為 37 美元。
* Guggenheim 的一位分析師積極上調評級至買入，並將目標價格調整至 62 美元。</p>
</div><p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Bristol-Myers Squibb options trades with real-time alerts from Benzinga Pro.</p>
<div class="lb-trans"><p>期權交易存在更高的風險和潛在的回報。精明的交易者通過不斷學習、調整策略、監控多個指標以及密切關注市場動態來管理這些風險。通過 Benzinga Pro 的實時警報，隨時瞭解百時美施貴寶的最新期權交易。</p>
</div>

解讀百時美施貴寶的期權活動：整體情況如何？